Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-23-071985)

Filing Details

Accession Number:: 0000950170-23-071985
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-12-20 18:00:07
Reporting Period:: 2023-12-18

Accepted Time:: 2023-12-20 18:00:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1789972	Cullinan Oncology Inc.	CGEM	Biological Products, (No Disgnostic Substances) (2836)	813867811

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1838671	Jeffrey Trigilio	C/O Cullinan Oncology, Inc. One Main Street, Suite 1350 Cambridge MA 02142	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-12-18	398	$8.22	85,839	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.